Cite

HARVARD Citation

    Tokunaga, M. et al. (2018). Clinical significance of cutaneous adverse reaction to mogamulizumab in relapsed or refractory adult T‐cell leukaemia‐lymphoma. British journal of haematology. pp. 539-542. [Online]. 
  
Back to record